Skip to main content
. 2021 Feb 1;29(8):4751–4761. doi: 10.1007/s00520-021-06009-y

Table 1.

Characteristics of participants and non-participants

Participants (N ≈ 151) Non-participants (N = 223)
Mean ± SD (range) % (N) Mean ± SD (range) % (N) p value
Socio-demographic
  Age (years) 24.1 ± 3.6 (18–30) 24.0 ± 3.4 (18–30) .659
  Sex (female) 61.6 (93) 40.8 (90) .000**
  Marital/relationship status
    Yes 51.0 (75)
    No 49.0 (72)
  Employment status
    Paid occupation 70.9 (105)
    No paid occupation 29.1 (43)
  Educational attainment
    Low 19.3 (28)
    Middle 48.3 (70)
    High 32.4 (47)
  Current education
    Low 3.1 (2)
    Middle 27.7 (18)
    High 69.2 (45)
Medical characteristics
  Age at diagnosis 10.5 ± 4.5 (.4–17) 10.6 ± 4.5 (0–18) .756
  Time since diagnosis 13.6 ± 3.8 (6–27) 13.5 ± 3.7 (6–28) .652
  Diagnosis
    Hematologic cancers 66.9 (101) 61.7 (142) .119
    CNS tumors 8.6 (13) 9.9 (22) .358
    Solid tumors 24.5 (37) 28.3 (63) .173
  Recurrence 13.9 (21)
  Treatmenta,b
    Surgery (S) 61.6 (93) 63.7 (142) .323
    Chemotherapy (CT) 95.4 (144) 95.5 (213) .522
    Radiotherapy (RT) 37.1 (56) 35.0 (78) .323
    SCT/BMT 7.3 (11) 13.5 (30) .012*
  Treatment combinationsb
    CT only 32.5 (49)
    CT + RT 6.0 (9)
    RT + S 4.6 (7)
    CT + S 30.5 (46)
    CT + S + RT 26.5 (40)

*p < 0.05; **p < 0.01 (two-sided)

aMore than one category possible

bTreatments for primary tumor and (if applicable) recurrence(s)